These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 27480453)
1. Exhaled breath condensate as a source of biomarkers for lung carcinomas. A focus on genetic and epigenetic markers-A mini-review. Youssef O; Sarhadi VK; Armengol G; Piirilä P; Knuuttila A; Knuutila S Genes Chromosomes Cancer; 2016 Dec; 55(12):905-914. PubMed ID: 27480453 [TBL] [Abstract][Full Text] [Related]
2. Exhaled breath condensate biomarkers for lung cancer. Campanella A; De Summa S; Tommasi S J Breath Res; 2019 Aug; 13(4):044002. PubMed ID: 31282387 [TBL] [Abstract][Full Text] [Related]
3. Exhaled breath condensate for lung cancer protein analysis: a review of methods and biomarkers. Hayes SA; Haefliger S; Harris B; Pavlakis N; Clarke SJ; Molloy MP; Howell VM J Breath Res; 2016 Jul; 10(3):034001. PubMed ID: 27380020 [TBL] [Abstract][Full Text] [Related]
4. Presence of cancer-associated mutations in exhaled breath condensates of healthy individuals by next generation sequencing. Youssef O; Knuuttila A; Piirilä P; Böhling T; Sarhadi V; Knuutila S Oncotarget; 2017 Mar; 8(11):18166-18176. PubMed ID: 28199989 [TBL] [Abstract][Full Text] [Related]
5. Clinical Application of Exhaled Breath Condensate in Diagnosis of Diseases. Zhao Z; Meng W Discov Med; 2024 Jun; 36(185):1154-1161. PubMed ID: 38926101 [TBL] [Abstract][Full Text] [Related]
6. Mass Spectrometry Analysis of the Exhaled Breath Condensate and Proposal of Dermcidin and S100A9 as Possible Markers for Lung Cancer Prognosis. Núñez-Naveira L; Mariñas-Pardo LA; Montero-Martínez C Lung; 2019 Aug; 197(4):523-531. PubMed ID: 31115649 [TBL] [Abstract][Full Text] [Related]
7. Exhaled breath condensate biomarkers for the early diagnosis of lung cancer using proteomics. López-Sánchez LM; Jurado-Gámez B; Feu-Collado N; Valverde A; Cañas A; Fernández-Rueda JL; Aranda E; Rodríguez-Ariza A Am J Physiol Lung Cell Mol Physiol; 2017 Oct; 313(4):L664-L676. PubMed ID: 28619761 [TBL] [Abstract][Full Text] [Related]
8. Exhaled breath analysis in suspected cases of non-small-cell lung cancer: a cross-sectional study. Corradi M; Poli D; Banda I; Bonini S; Mozzoni P; Pinelli S; Alinovi R; Andreoli R; Ampollini L; Casalini A; Carbognani P; Goldoni M; Mutti A J Breath Res; 2015 Jan; 9(2):027101. PubMed ID: 25634546 [TBL] [Abstract][Full Text] [Related]
9. 3p microsatellite signature in exhaled breath condensate and tumor tissue of patients with lung cancer. Carpagnano GE; Foschino-Barbaro MP; Spanevello A; Resta O; Carpagnano F; Mulé G; Pinto R; Tommasi S; Paradiso A Am J Respir Crit Care Med; 2008 Feb; 177(3):337-41. PubMed ID: 17962633 [TBL] [Abstract][Full Text] [Related]
10. Increased levels of exhaled sICAM1, sVCAM1, and sE-selectin in patients with non-small cell lung cancer. Zhou F; Chen J; Tao G; Zhu M; Xie W; Cao X Respir Med; 2014 Nov; 108(11):1670-6. PubMed ID: 25179787 [TBL] [Abstract][Full Text] [Related]
11. Exhaled Breath Condensate: An Update. Davis MD; Montpetit AJ Immunol Allergy Clin North Am; 2018 Nov; 38(4):667-678. PubMed ID: 30342587 [TBL] [Abstract][Full Text] [Related]
12. Non-invasive assessment of exhaled biomarkers in lung transplantation. Yates DH; Krishnan A; Chow S; Thomas PS J Breath Res; 2011 Jun; 5(2):024001. PubMed ID: 21498893 [TBL] [Abstract][Full Text] [Related]
13. Proteomics as a method for early detection of cancer: a review of proteomics, exhaled breath condensate, and lung cancer screening. Conrad DH; Goyette J; Thomas PS J Gen Intern Med; 2008 Jan; 23 Suppl 1(Suppl 1):78-84. PubMed ID: 18095050 [TBL] [Abstract][Full Text] [Related]
14. Methylation of P16 in exhaled breath condensate for diagnosis of non-small cell lung cancer. Xiao P; Chen JR; Zhou F; Lu CX; Yang Q; Tao GH; Tao YJ; Chen JL Lung Cancer; 2014 Jan; 83(1):56-60. PubMed ID: 24268095 [TBL] [Abstract][Full Text] [Related]
15. Concordance in molecular genetic analysis of tumour tissue, plasma, and exhaled breath condensate samples from lung cancer patients. Tetik Vardarli A; Pelit L; Aldag C; Korba K; Celebi C; Dizdas TN; Uzun UC; Tayfur E; Aykut A; Karakus HS; Baysal E; Goksel O; Pelit F; Yalcin F; Ertas FN; Basbinar Y; Veral A; Gunduz C; Goksel T J Breath Res; 2020 Apr; 14(3):036001. PubMed ID: 32031993 [TBL] [Abstract][Full Text] [Related]
16. Extraction and characterization of exosomes from the exhaled breath condensate and sputum of lung cancer patients and vulnerable tobacco consumers-potential noninvasive diagnostic biomarker source. Bano A; Yadav P; Sharma M; Verma D; Vats R; Chaudhry D; Kumar P; Bhardwaj R J Breath Res; 2024 Jul; 18(4):. PubMed ID: 38988301 [TBL] [Abstract][Full Text] [Related]
17. VEGF, TNF-alpha and 8-isoprostane levels in exhaled breath condensate and serum of patients with lung cancer. Dalaveris E; Kerenidi T; Katsabeki-Katsafli A; Kiropoulos T; Tanou K; Gourgoulianis KI; Kostikas K Lung Cancer; 2009 May; 64(2):219-25. PubMed ID: 18845357 [TBL] [Abstract][Full Text] [Related]
18. Analysis of cytokine pattern in exhaled breath condensate of patients with squamous cell lung carcinoma. Barta I; Kullmann T; Csiszer E; Antus B Int J Biol Markers; 2010; 25(1):52-6. PubMed ID: 20155714 [TBL] [Abstract][Full Text] [Related]
19. The impact of genetic markers on the diagnosis of lung cancer: a current perspective. Chorostowska-Wynimko J; Szpechcinski A J Thorac Oncol; 2007 Nov; 2(11):1044-51. PubMed ID: 17975498 [TBL] [Abstract][Full Text] [Related]
20. Exhaled biomarkers in lung cancer. Horváth I; Lázár Z; Gyulai N; Kollai M; Losonczy G Eur Respir J; 2009 Jul; 34(1):261-75. PubMed ID: 19567608 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]